drugset / Trial / NCT00005000
Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
CrossoverTreatment
Summary
The purpose of this study is to compare two drugs (nelfinavir \[NFV\] and efavirenz \[EFV\]) used in start-up anti-HIV treatment. Doctors want to see if one is better than the other in extending the time that viral load (level of HIV in the blood) is kept low. The study will also look at the response of the immune system to each drug.
Timeline
- Start
- 1999-12
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Efavirenz | Other / unclassified | — | — |
| Subject | Nelfinavir | Other / unclassified | — | — |
| Subject | keyhole limpet hemocyanin | Vaccine | — | — |
| Background | Didanosine | Small molecule | — | — |
| Background | Lamivudine | Other / unclassified | — | — |
| Background | Stavudine | Other / unclassified | — | — |
| Background | Zidovudine | Small molecule | — | — |